** Shares of vaccine makers Moderna MRNA.O, Novavax NVAX.O and Pfizer PFE.N gain as White House withdraws nomination of vaccine critic Dave Weldon to serve as director of the U.S. Centers for Disease Control and Prevention
** Moderna MRNA.O climbs 4.17% to $36.47, Novavax NVAX.O rises 1.85% to $8.25 and Pfizer PFE.N up marginally
** The former Republican congressman had been scheduled to appear before the Senate Health, Education, Labor and Pensions Committee on Thursday for a confirmation hearing
** The committee confirmed the withdrawal of the nomination and said the hearing had been canceled
** The stocks have been under pressure since Trump was elected for a second term, and selected well-known vaccine skeptic Robert F. Kennedy Jr to lead the Department of Health and Human Services, U.S.'s top health agency
(Reporting by Sriparna Roy in Bengaluru)
((Sriparna.Roy@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。